Vontobel Holding’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-50,000
Closed -$1.25M 1419
2025
Q4
$1.25M Buy
+50,000
New +$1.26M ﹤0.01% 698

Other funds holding PFE

Vontobel Holding's PFE Position: Q1 2026 in Review

Vontobel Holding reduced its Pfizer (PFE) stake by 22% in Q1 2026, selling an estimated $5.19M and leaving 706,645 shares worth $19.8M. The position accounts for 0.07% of the portfolio, ranked #208.

Vontobel Holding first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $45.1M in Q1 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Vontobel Holding held 706,645 shares of Pfizer worth $19.8M as of Q1 2026.
  • Vontobel Holding sold 194,932 Pfizer shares in Q1 2026, an estimated $5.19M.
  • Pfizer made up 0.07% of Vontobel Holding's portfolio in Q1 2026, its #208 holding.
  • Vontobel Holding first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • Vontobel Holding's Pfizer position peaked at $45.1M in Q1 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.